TCL Archive ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent. March 21, 2008
TCL Archive FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies June 12, 2009
TCL Archive In Brief: On “Clouds Of glory,” And An Italian Bike, Varmus Takes Office As 14th NIH Director November 26, 1993
TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
